Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiocca

Showing results (581-590 of 728) with videos related to

Pageof 73
Sort By:
Journal of Virology|February 10, 2012
The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferonChristopher A Alvarez-Breckenridge, Jianhua Yu, Richard Price, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 4, 2009
The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumorsBenjamin Kefas, Laurey Comeau, Desiree H Floyd, et al.
Neuro-Oncology Advances|April 16, 2021
Therapeutic cancer vaccines for pediatric malignancies: advances, challenges, and emerging technologiesHannah E Olsen, Geoffrey M Lynn, Pablo A Valdes, et al.
Cancer Research|April 18, 2001
Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivoA Jacobs, J G Tjuvajev, M Dubrovin, et al.
Gene Therapy|September 25, 1998
Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vectorU Herrlinger, C M Kramm, K S Aboody-Guterman, et al.
Neurology|June 16, 2005
Diagnostic criteria for schwannomatosisM MacCollin, E A Chiocca, D G Evans, et al.
Science Translational Medicine|January 31, 2024
Improved immunostaining of nanostructures and cells in human brain specimens through expansion-mediated protein decrowdingPablo A Valdes, Chih-Chieh Jay Yu, Jenna Aronson, et al.
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|December 15, 2019
Building a Safe and Healthy America: Eliminating Corporal Punishment via Positive ParentingGail Hornor, Saribel Garcia Quinones, Danielle Boudreaux, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma modelsMarilin S Koch, Mykola Zdioruk, Michal O Nowicki, et al.
Neoplasia (New York, N.Y.)|October 5, 2011
Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signalingPaula A Agudelo-Garcia, Jessica K De Jesus, Shante P Williams, et al.
Pageof 73

Showing results (581-590 of 728) with videos related to

Sort By:
Pageof 73
Journal of Virology|February 10, 2012
The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferonChristopher A Alvarez-Breckenridge, Jianhua Yu, Richard Price, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 4, 2009
The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumorsBenjamin Kefas, Laurey Comeau, Desiree H Floyd, et al.
Neuro-Oncology Advances|April 16, 2021
Therapeutic cancer vaccines for pediatric malignancies: advances, challenges, and emerging technologiesHannah E Olsen, Geoffrey M Lynn, Pablo A Valdes, et al.
Cancer Research|April 18, 2001
Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivoA Jacobs, J G Tjuvajev, M Dubrovin, et al.
Gene Therapy|September 25, 1998
Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vectorU Herrlinger, C M Kramm, K S Aboody-Guterman, et al.
Neurology|June 16, 2005
Diagnostic criteria for schwannomatosisM MacCollin, E A Chiocca, D G Evans, et al.
Science Translational Medicine|January 31, 2024
Improved immunostaining of nanostructures and cells in human brain specimens through expansion-mediated protein decrowdingPablo A Valdes, Chih-Chieh Jay Yu, Jenna Aronson, et al.
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|December 15, 2019
Building a Safe and Healthy America: Eliminating Corporal Punishment via Positive ParentingGail Hornor, Saribel Garcia Quinones, Danielle Boudreaux, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma modelsMarilin S Koch, Mykola Zdioruk, Michal O Nowicki, et al.
Neoplasia (New York, N.Y.)|October 5, 2011
Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signalingPaula A Agudelo-Garcia, Jessica K De Jesus, Shante P Williams, et al.
Pageof 73